EGFR and breast cancer: The abnormal activation of epidermal growth factor receptor (EGFR) tyrosine kinase is responsible for promoting various tumor types, including lung cancer and breast cancer either via an increase in the levels of extracellular ligand, hetero-dimerization of EGFR or its mutational activation2, 3.